Update on Intravitreal Injectable Drugs and Dry AMD Treatments episode artwork

EPISODE · Aug 10, 2023 · 40 MIN

Update on Intravitreal Injectable Drugs and Dry AMD Treatments

from Experts InSight

Drs. M. Ali Khan, Ajay Kuriyan, and Sarah Read join host Jay Sridhar to discuss recent developments in intravitreal injectable drugs, including 8-mg aflibercept not initially approved by the FDA, the upcoming PDUFA date for on-label bevacizumab, and approaching injections for dry age-related macular degeneration (AMD). For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Episode metadata supplied by the publisher feed · Published Aug 10, 2023

Embed this episode

NOW PLAYING

Update on Intravitreal Injectable Drugs and Dry AMD Treatments

0:00 40:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Experts InSight?

This episode is 40 minutes long.

When was this Experts InSight episode published?

This episode was published on August 10, 2023.

Can I download this Experts InSight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!